trial
as of 2026-07-01Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia
NCTId NCT01725334
at a glance
Phase 1 · Withdrawn
Enrollment 0 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2015-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2012-09
Primary completion
2015-09
Eligibility
ALL · 25 Years · 60 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
University Health Network, TorontoCollaborator
Schizophrenia Society of OntarioCollaborator
Investigators
1
Zafiris J Daskalakis, MD, PhDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
0
Phase
PHASE1
Primary Completion Date
2015-09
Status
WITHDRAWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator